1088 related articles for article (PubMed ID: 19356714)
1. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.
Purushotham A; Schug TT; Xu Q; Surapureddi S; Guo X; Li X
Cell Metab; 2009 Apr; 9(4):327-38. PubMed ID: 19356714
[TBL] [Abstract][Full Text] [Related]
2. Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1.
Rodgers JT; Puigserver P
Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12861-6. PubMed ID: 17646659
[TBL] [Abstract][Full Text] [Related]
3. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
Barroso E; Rodríguez-Calvo R; Serrano-Marco L; Astudillo AM; Balsinde J; Palomer X; Vázquez-Carrera M
Endocrinology; 2011 May; 152(5):1848-59. PubMed ID: 21363937
[TBL] [Abstract][Full Text] [Related]
4. SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidation.
Laurent G; de Boer VC; Finley LW; Sweeney M; Lu H; Schug TT; Cen Y; Jeong SM; Li X; Sauve AA; Haigis MC
Mol Cell Biol; 2013 Nov; 33(22):4552-61. PubMed ID: 24043310
[TBL] [Abstract][Full Text] [Related]
5. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.
Azar S; Udi S; Drori A; Hadar R; Nemirovski A; Vemuri KV; Miller M; Sherill-Rofe D; Arad Y; Gur-Wahnon D; Li X; Makriyannis A; Ben-Zvi D; Tabach Y; Ben-Dov IZ; Tam J
Mol Metab; 2020 Dec; 42():101087. PubMed ID: 32987186
[TBL] [Abstract][Full Text] [Related]
6. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway.
Finck BN; Gropler MC; Chen Z; Leone TC; Croce MA; Harris TE; Lawrence JC; Kelly DP
Cell Metab; 2006 Sep; 4(3):199-210. PubMed ID: 16950137
[TBL] [Abstract][Full Text] [Related]
7. High-fat feeding in cardiomyocyte-restricted PPARdelta knockout mice leads to cardiac overexpression of lipid metabolic genes but fails to rescue cardiac phenotypes.
Li Y; Cheng L; Qin Q; Liu J; Lo WK; Brako LA; Yang Q
J Mol Cell Cardiol; 2009 Oct; 47(4):536-43. PubMed ID: 19595695
[TBL] [Abstract][Full Text] [Related]
8. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.
Li Y; Wong K; Giles A; Jiang J; Lee JW; Adams AC; Kharitonenkov A; Yang Q; Gao B; Guarente L; Zang M
Gastroenterology; 2014 Feb; 146(2):539-49.e7. PubMed ID: 24184811
[TBL] [Abstract][Full Text] [Related]
9. Hepatic PGC-1beta overexpression induces combined hyperlipidemia and modulates the response to PPARalpha activation.
Lelliott CJ; Ljungberg A; Ahnmark A; William-Olsson L; Ekroos K; Elmgren A; Arnerup G; Shoulders CC; Oscarsson J; Lindén D
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2707-13. PubMed ID: 17932310
[TBL] [Abstract][Full Text] [Related]
10. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.
Rodgers JT; Lerin C; Haas W; Gygi SP; Spiegelman BM; Puigserver P
Nature; 2005 Mar; 434(7029):113-8. PubMed ID: 15744310
[TBL] [Abstract][Full Text] [Related]
11. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
12. SIRT1 performs a balancing act on the tight-rope toward longevity.
Purushotham A; Schug TT; Li X
Aging (Albany NY); 2009 Jul; 1(7):669-73. PubMed ID: 20157548
[TBL] [Abstract][Full Text] [Related]
13. Formononetin promotes fatty acid β-oxidation to treat non-alcoholic steatohepatitis through SIRT1/PGC-1α/PPARα pathway.
Liao J; Xie X; Wang N; Wang Y; Zhao J; Chen F; Qu F; Wen W; Miao J; Cui H
Phytomedicine; 2024 Feb; 124():155285. PubMed ID: 38185065
[TBL] [Abstract][Full Text] [Related]
14. CDKN2A/p16INK4a suppresses hepatic fatty acid oxidation through the AMPKα2-SIRT1-PPARα signaling pathway.
Deleye Y; Cotte AK; Hannou SA; Hennuyer N; Bernard L; Derudas B; Caron S; Legry V; Vallez E; Dorchies E; Martin N; Lancel S; Annicotte JS; Bantubungi K; Pourtier A; Raverdy V; Pattou F; Lefebvre P; Abbadie C; Staels B; Haas JT; Paumelle R
J Biol Chem; 2020 Dec; 295(50):17310-17322. PubMed ID: 33037071
[TBL] [Abstract][Full Text] [Related]
15. Hepatic ATF6 Increases Fatty Acid Oxidation to Attenuate Hepatic Steatosis in Mice Through Peroxisome Proliferator-Activated Receptor α.
Chen X; Zhang F; Gong Q; Cui A; Zhuo S; Hu Z; Han Y; Gao J; Sun Y; Liu Z; Yang Z; Le Y; Gao X; Dong LQ; Gao X; Li Y
Diabetes; 2016 Jul; 65(7):1904-15. PubMed ID: 27207533
[TBL] [Abstract][Full Text] [Related]
16. Activation of type 2 cannabinoid receptors (CB2R) promotes fatty acid oxidation through the SIRT1/PGC-1α pathway.
Zheng X; Sun T; Wang X
Biochem Biophys Res Commun; 2013 Jul; 436(3):377-81. PubMed ID: 23747418
[TBL] [Abstract][Full Text] [Related]
17. ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1α/PPAR-α signaling.
Khan SA; Sathyanarayan A; Mashek MT; Ong KT; Wollaston-Hayden EE; Mashek DG
Diabetes; 2015 Feb; 64(2):418-26. PubMed ID: 25614670
[TBL] [Abstract][Full Text] [Related]
18. PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease.
Huang K; Du M; Tan X; Yang L; Li X; Jiang Y; Wang C; Zhang F; Zhu F; Cheng M; Yang Q; Yu L; Wang L; Huang D; Huang K
J Hepatol; 2017 May; 66(5):962-977. PubMed ID: 27979751
[TBL] [Abstract][Full Text] [Related]
19. A pan-PPAR ligand induces hepatic fatty acid oxidation in PPARalpha-/- mice possibly through PGC-1 mediated PPARdelta coactivation.
Røst TH; Haugan Moi LL; Berge K; Staels B; Mellgren G; Berge RK
Biochim Biophys Acta; 2009 Nov; 1791(11):1076-83. PubMed ID: 19577662
[TBL] [Abstract][Full Text] [Related]
20. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
